Table 4 Multivariate analysis of disease-free and overall survival
Disease-free survival | Oesophageal/GOJ | Gastric | ||
|---|---|---|---|---|
Covariate | Hazard ratio (95 % CI) | P-value | Hazard ratio (95%CI) | P-value |
Differentiation | 0.58 (0.39–0.86) | 0.007 | - | - |
N-stage | 1.59 (1.05–2.40) | 0.028 | - | - |
T-stage | - | - | 1.9 (1.13–3.13) | 0.015 |
Overall survival | Oesophageal/GOJ | Gastric | ||
Covariate | Hazard ratio (95 % CI) | P-value | Hazard ratio (95%CI) | P-value |
Differentiation | 0.47 (0.31–0.72) | 0.000 | 0.45 (0.26–0.78) | 0.005 |
N-stage | 1.64 (1.06–2.53) | 0.027 | - | - |
Local relapse | 2.92 (1.01–8.48) | 0.049 | 3.98 (1.36–11.69) | 0.012 |
Distant relapse | 5.40 (3.28–8.90) | 0.000 | 9.10 (5.13–16.14) | 0.000 |
Local and distant relapse | 3.61 (1.61–8.10) | 0.002 | 8.75 (3.44–22.24) | 0.000 |
Neoadjuvant, adjuvant or perioperative therapy | - | - | 0.31 (0.19–0.52) | 0.000 |